This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Benzinga21:42

Guggenheim Initiates Coverage On Cidara Therapeutics With Buy Rating, Announces Price Target of $33

Benzinga19:31 · Ratings

Guggenheim Initiates Cidara Therapeutics(CDTX.US) With Buy Rating, Announces Target Price $33

Futu News19:31 · Ratings

Needham Maintains Cidara Therapeutics(CDTX.US) With Buy Rating, Maintains Target Price $25

Futu News18:37 · Ratings

Positive Outlook for Cidara Therapeutics Amid Strategic Advancements and Financial Stability

TipRanks18:16

Cidara Therapeutics GAAP EPS of -$2.38 Beats by $1.87

Seeking Alpha07:20